Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Single-arm, Multicenter, Long-term Study to Evaluate Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Pediatric Subjects With Epilepsy

NCT01364597 is registered in ClinicalTrials.gov with UCB Pharma SA as lead sponsor.

NCT NCT01364597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01364597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Single-arm, Multicenter, Long-term Study to Evaluate Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Pediatric Subjects With Epilepsy
Lead sponsor
UCB Pharma SA
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2011
Completion date
February 3, 2022
Enrollment
257 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy